Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Y Huang, M.D., Ph.D.

Concepts (354)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Raymond Huang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Raymond Huang has written about over time.
Angiogenesis Inhibitors, 9 publications between 2013 and 2021, average publication date July 2016. Neoplasm Recurrence, Local, 15 publications between 2013 and 2023, average publication date May 2018. Tumor Burden, 9 publications between 2014 and 2023, average publication date April 2019. Glutarates, 2 publications between 2018 and 2020, average publication date April 2019. Glioblastoma, 26 publications between 2012 and 2024, average publication date June 2019. Magnetic Resonance Imaging, 58 publications between 2012 and 2024, average publication date October 2019. Brain Neoplasms, 64 publications between 2012 and 2024, average publication date February 2020. Isocitrate Dehydrogenase, 12 publications between 2016 and 2024, average publication date May 2020. Glioma, 35 publications between 2013 and 2024, average publication date September 2020. Central Nervous System Neoplasms, 3 publications between 2019 and 2021, average publication date September 2020. Meningeal Neoplasms, 12 publications between 2017 and 2024, average publication date February 2021. Meningioma, 10 publications between 2017 and 2024, average publication date March 2021. Artificial Intelligence, 9 publications between 2019 and 2024, average publication date July 2022.

To see the data from this visualization as text, click here.
Huang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (354)
Explore
_
Co-Authors (110)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.